Canada’s overdose crisis continues to grow, claiming nearly 4,000 lives last year alone. In the midst of this emergency, more than 1,000 frontline workers converged in Edmonton last month for Stimulus 2018, Canada’s first national conference on harm reduction and drug policy.
“The time for excuses is over. It’s very, very clear that the risk is zero. If you are on suppressive antiretroviral treatment you are sexually non-infectious” — Dr. Alison Rodger of University College London, lead author of PARTNER 2, presenting at the 22nd International AIDS Conference in Amsterdam, July 25, 2018. It’s difficult to overstate the power of this message for people with HIV, such as myself, because it changes what it means to live with HIV. It opens up social, sexual and reproductive choices we and our sexual partners never thought would be possible. It encourages those of us...
Supervised injection services (SIS) provide safer spaces for people to inject drugs and help reduce the risk of overdose and behaviours linked to HIV and hepatitis C. Now more than ever, as Canada continues to experience an overdose crisis that took nearly 4,000 lives in 2017, people who use drugs need barrier-free access to these services. Policing practices – such as arresting people near harm reduction programs – can be major barriers to SIS attendance and operation. We recently completed a study focused on how to improve SIS-police relationships. For this research, we interviewed SIS managers, program coordinators and police...
At this year’s International AIDS Conference (AIDS 2018) in Amsterdam, the Netherlands, we witnessed several pivotal developments in the global HIV response. We also saw some setbacks in our efforts to prevent infections and improve the lives of people living with HIV. From clinical science and epidemiology to human rights and advocacy, here are some highlights of the good news and the bad news from AIDS 2018.
The Canadian Network on Hepatitis C (CanHepC) is leading a national effort to develop a consensus blueprint to meet the World Health Organization’s hepatitis C elimination targets by 2030. The goal of the blueprint is to guide various stakeholders with specific and measurable objectives on how to address hepatitis C in different Canadian contexts. I’m excited for the initial draft of the blueprint, coming out this fall, as it will greatly impact my work.
This past year the Canadian Aboriginal AIDS Network (CAAN) held its annual gathering, on the theme of “transforming wholistic approaches to Indigenous health.” It’s a gathering of First Nations, Métis and Inuit people, combining a business meeting, a gathering of Aboriginal people with HIV/AIDS, and the ‘Wise Practices’ research conference. But more importantly, it is a gathering of colleagues who have become friends, clients who have become peers, people with HIV who have become community leaders, and an extended family. Also present are elders welcoming delegates to their traditional lands, and children – the younger ones mostly playing with each...
